Fibrosis-4

Biomarker1 paper

Humans1

Latest

17

CureusReview2 Oct

Fibrosis-Driven Cardiovascular Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease: Emerging Links With Atherosclerotic Cardiovascular Disease

JAMA Internal MedicineHumans21 Sep

Steatotic Liver Disease Risk Scores to Predict Cirrhosis and Hepatocellular Carcinoma

Nutrition, Metabolism, and Cardiovascular DiseasesHumans19 Sep

Association of lipoprotein(a) and MASLD in predicting carotid atherosclerosis in asymptomatic individuals: a large scale cross-sectional and longitudinal study

Frontiers in MedicineReview16 Sep

A fibrosis-informed refinement of the intermediate-risk stratum for statin allocation: a liver-derived hypothesis anchored to the 2026 PREVENT-based guideline framework

Frontiers in EndocrinologyHumans16 Sep

Association of MASLD with chronic kidney disease according to metabolic profiles and fibrosis severity: a KNHANES analysis

Chronic kidney disease

Frontiers in EndocrinologyReview16 Sep

Incremental effects of SGLT2 inhibitors, GLP-1 receptor agonists, and pioglitazone in type 2 diabetes and MASLD across Asian study settings: a systematic review and meta-analysis

SGLT2 inhibitors

Gut and LiverHumans15 Sep

Differential Cancer Risks and Noninvasive Predictors in MASLD, MetALD, and ALD: A Longitudinal Analysis

Clinical Gastroenterology and HepatologyHumans10 Sep

Assessing Strategies to Mitigate the Effect of Age When Using FIB-4 Index to Screen for MASLD-Related Liver Fibrosis

Respiratory InvestigationHumans7 Sep

Association of liver fibrosis with incident chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease

European Heart JournalHumans6 Sep

Subclinical liver disease and incident cardiovascular events

Cardiovascular disease